Abstract

In recent years, the significance of detecting minimal/measurable residual disease (MRD) in chronic lymphocytic leukemia (CLL) has increased due to the availability of highly effective therapeutic agents. Flow cytometry provides notable cost-effectiveness and immediacy, with an expected sensitivity level of approximately 10−4. The critical aspect of MRD detection via flow cytometry lies in accurately defining the region containing tumor cells. However, a subset of CLL, known as CLL with atypical immunophenotype, exhibits a distinct cell surface marker expression pattern that can make MRD detection challenging, because these markers often resemble those of normal B cells. To enhance the sensitivity of MRD detection in such atypical cases of CLL, we have capitalized on the observation that cell surface immunoglobulin (sIg) light chains tend to be expressed at a higher level in this subtype. For every four two-dimensional plots of cell surface markers, we used a plot to evaluate the expression of sIg kappa/lambda light chains and identified regions where the kappa/lambda ratio of sIg light chains deviated from a designated threshold within the putative CLL cell region. Using this method, we could detect atypical CLL cells at a level of 10−4. We propose this method as an effective MRD assay.

Details

Title
The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype
Author
Aruga, Yu 1 ; Ikeda, Chiaki 2 ; Matsushita, Hiromichi 3 ; Makita, Shinichi 4 ; Fukuhara, Suguru 4 ; Munakata, Wataru 4 ; Izutsu, Koji 4 ; Matsui, Hirotaka 1 

 National Cancer Center Hospital, Department of Laboratory Medicine, Tokyo, Japan (GRID:grid.497282.2); Kumamoto University, Department of Medical Oncology and Translational Research, Graduate School of Medical Sciences, Kumamoto, Japan (GRID:grid.274841.c) (ISNI:0000 0001 0660 6749) 
 National Cancer Center Hospital, Department of Laboratory Medicine, Tokyo, Japan (GRID:grid.497282.2) 
 National Cancer Center Hospital, Department of Laboratory Medicine, Tokyo, Japan (GRID:grid.497282.2); Keio University School of Medicine, Department of Laboratory Medicine, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
 National Cancer Center Hospital, Department of Hematology, Tokyo, Japan (GRID:grid.497282.2) 
Pages
13452
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3066605848
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.